JPRN-UMIN000022015
Completed
未知
A clinical study for evaluating the efficacy of soft drink containing reduced type of indigestible dextrin on the suppression of the elevation of postprandial serum triglyceride. -Randomised double-blind placebo-controlled trial - A clinical study for evaluating the efficacy of soft drink containing reduced type of indigestible dextrin on the suppression of the elevation of postprandial serum triglyceride. -Randomised double-blind placebo-controlled trial
ConditionsHealthy adult
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Healthy adult
- Sponsor
- KSO Corporation
- Enrollment
- 90
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\) Individuals who use oral medication affecting lipid metabolism (2\) Individuals who constantly use supplements and/or functional foods, including food for specified health use and/or food with function claims, affecting lipid metabolism (3\) Individuals whose IBM is less than 18 or 30 and over at the screening checkup (4\) Individuals who can't stop drinking for 2 days until the screening checkup (5\) Individuals who declare the allergy symptoms against high\-fat diets (6\) Individuals who are suffered from or under treatment of serious disease (e.g., diabetes, liver disease, kidney disease, and/or heart disease), thyroid gland disease, adrenal gland disease, and/or metabolic disorder (7\) Individuals who have a chronic disease and use medicines continuously (8\) Individuals who have a history of digestive disease and/or surgical history affecting digestion and absorption (9\) Individuals who are judged as unsuitable for the study based on the results of blood test (10\) Individuals who have donated over 200 mL of blood and/or blood component within the last one month prior to the current study or over 400 mL of blood and/or blood component within the last three months prior to the current study. (11\) Individuals who are diagnosed as familial hyperlipidemia (12\) Individuals who are diagnosed as severe anemia and not suitable for frequent collection of blood (13\) Individuals who are under treatment or have a history of drug/alcohol dependence (14\) Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics (15\) Individuals who are pregnant or breast\-feeding, or have the will of pregnancy during the study period (16\) Individuals who are judged as unsuitable for the study by the investigator for the other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A clinical study for evaluating the efficacy of soft drink containing reduced type of indigestible dextrin on the function of intestinal regulation to subjects having tendency toward constipation. -Randomised double-blind placebo-controlled trialHealthy adultJPRN-UMIN000021665KSO Corporation50
Completed
Phase 2
effect of Sovodak in patients with hepatitis C and HIV-1Condition 1: Hepatitis C and HIV. Condition 2: Human immunodeficiency virus.Acute hepatitis CHuman immunodeficiency virus [HIV] diseaseIRCT20180924041107N1Tabriz University of Medical Sciences22
Completed
Phase 2
The study evaluating the efficacy and safety of sorafenib in patients with differentiated thyroid cancer not amendable to radioactive iodine therapy and other alternative treatment.Thyroid cancerJPRN-UMIN000017777niversity of Tsukuba47
Not yet recruiting
Phase 2
Seenthil choornamHealth Condition 1: K279- Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforationCTRI/2024/05/067586ational Institute of Siddha
Not yet recruiting
Phase 2
A clinical study to evaluate tha effectiveness of masha taila through greeva basti and nasya karma along with rasnadi guggulu in the cases of cervical spodylosisHealth Condition 1: M478- Other spondylosisCTRI/2021/04/032653State Ayurvedic College and Hospital Lucknow